Strong Triage Maximizes Innovation Resources
The costs of innovation have rose to the extent that discovery gaps exist for whole industries. The pharmaceutical industry has been the focus of many studies as to why such a discovery gap (drugs with expiring patents coupled with few new molecular entities) has existed since the mid-1990s. Clearly, large expenditures in genomic research have … Read more